Lab-grown meat must now say so—clearly and upfront.

What it does

This bill requires cell-cultivated meat and poultry products (grown from animal cells in labs, not from live animals) and plant-based meat alternatives to be clearly labeled as such on packaging. It mandates that labels prominently display "cell-cultivated" or "plant-based alternative protein product" immediately next to the product name, along with disclaimers stating the product is not derived from naturally produced meat or poultry. The bill also shifts regulatory authority: the USDA will oversee cell-cultivated products under meat and poultry inspection laws, while the FDA handles pre-market safety review of cell-culture processes.

Why we flagged it

The bill's operative mechanism is mandatory disclosure—requiring prominent, conspicuous labeling of cell-cultivated and plant-based protein products to distinguish them from conventional meat. This is a consumer-protection and transparency measure, not a subsidy, carve-out, or deregulation.

What the text implies

• Regulatory authority over cell-cultivated products shifts from FDA (primary) to USDA (primary), with FDA retained for pre-market safety review of cell-culture processes. This dual-agency model may create coordination gaps or enforcement inconsistencies if the MOU revision is unclear.
• The bill defines plant-based products broadly as foods 'manufactured to appear as meat, poultry, or a food product thereof'—potentially capturing products that mimic meat aesthetically but are not marketed as meat substitutes, creating unintended labeling obligations.
• Standards of identity for cell-cultivated and plant-based products must be developed within 180 days; if standards are vague or conflict with existing FDA/USDA definitions, manufacturers may face compliance uncertainty and litigation risk.
• The labeling requirements are strict (prominent, conspicuous, legible, uniform size, immediately adjacent to product name) and apply to all cell-cultivated and plant-based products; non-compliance triggers misbranding liability under existing meat/poultry inspection laws, exposing manufacturers to enforcement action.
• Conventional meat and poultry producers benefit indirectly from mandatory differentiation labeling, which may reinforce consumer perception of cell-cultivated and plant-based products as distinct categories, potentially slowing market adoption of alternatives.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Consumers gain clear, mandatory disclosure to distinguish lab-grown and plant-based products from conventional meat, enabling informed purchasing decisions. The labeling requirements are transparent and protective of consumer choice, with no offsetting restrictions on citizens' rights or access to information.

Named in the bill

USDA (Secretary of Agriculture), FDA (Secretary of Health and Human Services), Federal Meat Inspection Act, Poultry Products Inspection Act, Federal Food, Drug, and Cosmetic Act, Cell-cultivated protein manufacturers, Plant-based protein manufacturers, Conventional meat and poultry producers

Where it stands

6 cosponsors: 5 Republicans, 1 Democrats.

• Apr 30, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Apr 30, 2026 — Referred to Senate Committee on Agriculture, Nutrition, and Forestry · Congress.gov: “Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.